ArticleFrontiers in physiology2026
Improvement of occipital neuralgia by pulsed radiofrequency of the greater occipital nerve combined with local magnesium sulfate injection: a randomized controlled study.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the safety and efficacy of magnesium sulfate as an adjuvant in pulsed radiofrequency (PRF) stimulation of the greater occipital nerve for the treatment of occipital neuralgia. Methods: Consecutive patients diagnosed with neurogenic occipital neuralgia who attended the Pain Department of Changzhi People's Hospital were recruited for this study, randomly assigned to control group and experimental group. The control group received PRF treatment on the affected side only, whereas the experimental group received an additional perineural injection of 5% magnesium sulfate (150 mg) around the greater occipital nerve immediately after PRF. NRS scores, pain duration, and pain frequency were compared between the two groups at baseline (T0), 30 days post-treatment (T1), and 60 days post-treatment (T2), at these identical time points, ultrasonography was performed to measure the thicknesses of the ipsilateral semispinalis capitis, obliquus capitis inferior, and deep fascia superficial to the obliquus capitis inferior, along with vertebral artery systolic flow parameters. Additionally, shear wave elastography (SWE) was used to measure the maximum shear wave velocity (SWVmax) and mean shear wave velocity (SWVmean) of the semispinalis capitis to assess cervical musculature status. Results: A total of 91 patients completed the entire study, with 43 in the control group and 48 in the experimental group. No significant between-group differences were observed preoperatively in occipital neuralgia symptoms (NRS scores, pain duration, and frequency), thickness of the ipsilateral perineural muscles and fascia, shear wave elastography of the semispinalis capitis, or vertebral artery hemodynamic parameters ( Conclusion: Local magnesium-sulfate injection enhances pulsed radiofrequency efficacy by relieving perineural muscle spasm and improving vertebral-artery hemodynamics, leading to sustained reductions in headache intensity, duration, and frequency with an excellent safety profile.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.